These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


158 related items for PubMed ID: 31295009

  • 21. Ivabradine Improves Cardiac Function and Increases Exercise Capacity in Patients with Chronic Heart Failure.
    Pei H, Miao W, Xie WZ, Wang W, Zhao D, Su GH, Zhao Z.
    Int Heart J; 2019 Jul 27; 60(4):899-909. PubMed ID: 31308326
    [Abstract] [Full Text] [Related]

  • 22. Assessment of Complementary Treatment with Yiqi Fumai Lyophilized Injection on Acute Decompensated Ischemic Heart Failure (ACT-ADIHF): Rationale and Design of a Multicenter, Randomized, Controlled Trial.
    Wang X, Zhao Z, Hou Y, Tang E, Zhao G, Wang S, Bi Y, Zhong C, Ren M, Zhang J, Mao J, Zhang B.
    Cardiovasc Drugs Ther; 2018 Jun 27; 32(3):295-300. PubMed ID: 29713851
    [Abstract] [Full Text] [Related]

  • 23. Bedside B-type natriuretic peptide and functional capacity in chronic heart failure.
    Jourdain P, Funck F, Bellorini M, Guillard N, Loiret J, Thebault B, Desnos M, Duboc D.
    Eur J Heart Fail; 2003 Mar 27; 5(2):155-60. PubMed ID: 12644005
    [Abstract] [Full Text] [Related]

  • 24. Clinical assessment of complementary treatment with Qishen Yiqi dripping pills on ischemic heart failure: study protocol for a randomized, double-blind, multicenter, placebo-controlled trial (CACT-IHF).
    Hou YZ, Wang S, Zhao ZQ, Wang XL, Li B, Soh SB, Mao JY.
    Trials; 2013 May 14; 14():138. PubMed ID: 23672353
    [Abstract] [Full Text] [Related]

  • 25. A Phase II, randomized, double-blind, multicenter, based on standard therapy, placebo-controlled study of the efficacy and safety of recombinant human neuregulin-1 in patients with chronic heart failure.
    Gao R, Zhang J, Cheng L, Wu X, Dong W, Yang X, Li T, Liu X, Xu Y, Li X, Zhou M.
    J Am Coll Cardiol; 2010 May 04; 55(18):1907-14. PubMed ID: 20430261
    [Abstract] [Full Text] [Related]

  • 26. [The clinical value of B-type natriuretic peptide in the diagnosis of left heart failure].
    Zhao XY, Yang YJ, Zhang J, Dang AM, Ni XH, Huang J, Kang S, Ma WH, Zhao DY.
    Zhonghua Yi Xue Za Zhi; 2006 May 09; 86(17):1165-9. PubMed ID: 16796855
    [Abstract] [Full Text] [Related]

  • 27. Effect of ivabradine in patients with heart failure with preserved ejection fraction: the EDIFY randomized placebo-controlled trial.
    Komajda M, Isnard R, Cohen-Solal A, Metra M, Pieske B, Ponikowski P, Voors AA, Dominjon F, Henon-Goburdhun C, Pannaux M, Böhm M, prEserveD left ventricular ejectIon fraction chronic heart Failure with ivabradine studY (EDIFY) Investigators.
    Eur J Heart Fail; 2017 Nov 09; 19(11):1495-1503. PubMed ID: 28462519
    [Abstract] [Full Text] [Related]

  • 28. Effect of coenzyme Q10 in Europeans with chronic heart failure: A sub-group analysis of the Q-SYMBIO randomized double-blind trial.
    Mortensen AL, Rosenfeldt F, Filipiak KJ.
    Cardiol J; 2019 Nov 09; 26(2):147-156. PubMed ID: 30835327
    [Abstract] [Full Text] [Related]

  • 29. Randomized, double-blind, placebo-controlled study to evaluate the effect of two dosing regimens of darbepoetin alfa in patients with heart failure and anaemia.
    van Veldhuisen DJ, Dickstein K, Cohen-Solal A, Lok DJ, Wasserman SM, Baker N, Rosser D, Cleland JG, Ponikowski P.
    Eur Heart J; 2007 Sep 09; 28(18):2208-16. PubMed ID: 17681958
    [Abstract] [Full Text] [Related]

  • 30. Clinical effects of Xinmailong therapy in patients with chronic heart failure.
    Ma Q, Luo Y, Guo P, Gao G, Yang M, Sablok G, Zhang Y, Zhou F.
    Int J Med Sci; 2013 Sep 09; 10(5):624-33. PubMed ID: 23569425
    [Abstract] [Full Text] [Related]

  • 31. [Network Meta-analysis of efficacy and safety of different traditional Chinese medicine injections in treating post-acute myocardial infarction heart failure].
    Sun Y, Qiao LJ, Wei JJ, Li B, Gao Y, Zhu MJ.
    Zhongguo Zhong Yao Za Zhi; 2023 Nov 09; 48(21):5932-5945. PubMed ID: 38114189
    [Abstract] [Full Text] [Related]

  • 32. Testosterone Replacement Therapy in Deficient Patients With Chronic Heart Failure: A Randomized Double-Blind Controlled Pilot Study.
    Navarro-Peñalver M, Perez-Martinez MT, Gómez-Bueno M, García-Pavía P, Lupón-Rosés J, Roig-Minguell E, Comin-Colet J, Bayes-Genis A, Noguera JA, Pascual-Figal DA.
    J Cardiovasc Pharmacol Ther; 2018 Nov 09; 23(6):543-550. PubMed ID: 29929385
    [Abstract] [Full Text] [Related]

  • 33. [Treatment of chronic heart failure by shencao tongmai granule: a multi-centered, double-blinded, randomized, parallel controlled trial].
    Wang C, Zhang Y, Gong LH.
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2012 May 09; 32(5):612-5. PubMed ID: 22679719
    [Abstract] [Full Text] [Related]

  • 34. High levels of plasma brain natriuretic peptide and interleukin-6 after optimized treatment for heart failure are independent risk factors for morbidity and mortality in patients with congestive heart failure.
    Maeda K, Tsutamoto T, Wada A, Mabuchi N, Hayashi M, Tsutsui T, Ohnishi M, Sawaki M, Fujii M, Matsumoto T, Kinoshita M.
    J Am Coll Cardiol; 2000 Nov 01; 36(5):1587-93. PubMed ID: 11079662
    [Abstract] [Full Text] [Related]

  • 35. Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial.
    Jabbour A, Macdonald PS, Keogh AM, Kotlyar E, Mellemkjaer S, Coleman CF, Elsik M, Krum H, Hayward CS.
    J Am Coll Cardiol; 2010 Apr 27; 55(17):1780-7. PubMed ID: 20413026
    [Abstract] [Full Text] [Related]

  • 36. Randomized Trial of Effect of Urate-Lowering Agent Febuxostat in Chronic Heart Failure Patients with Hyperuricemia (LEAF-CHF).
    Yokota T, Fukushima A, Kinugawa S, Okumura T, Murohara T, Tsutsui H.
    Int Heart J; 2018 Sep 26; 59(5):976-982. PubMed ID: 30101851
    [Abstract] [Full Text] [Related]

  • 37. Psychomotor speed as a predictor of functional status in older chronic heart failure (CHF) patients attending cardiac rehabilitation.
    Pierobon A, Granata N, Torlaschi V, Vailati C, Radici A, Maestri R, Pavesi C, Sommaruga M, Gazzi L, Bertolotti G, Sarzi Braga S, Monelli M, Zanelli E, Giardini A.
    PLoS One; 2020 Sep 26; 15(7):e0235570. PubMed ID: 32614895
    [Abstract] [Full Text] [Related]

  • 38. [Qangxin Granule Intervened Chronic Heart Failure Rats with Xin-qi Deficiency Complicated Blood Stasis and Edema Syndrome: an Experimental Study].
    Lin JM, Guo WX, Wang Y, Liu Y, Li YR, Li H, Zhou J.
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2015 May 26; 35(5):583-9. PubMed ID: 26159024
    [Abstract] [Full Text] [Related]

  • 39. Effects of candesartan on cardiac sympathetic nerve activity in patients with congestive heart failure and preserved left ventricular ejection fraction.
    Kasama S, Toyama T, Kumakura H, Takayama Y, Ichikawa S, Suzuki T, Kurabayashi M.
    J Am Coll Cardiol; 2005 Mar 01; 45(5):661-7. PubMed ID: 15734608
    [Abstract] [Full Text] [Related]

  • 40. Qishen Taohong Granule () as Adjuvant Therapy for Improving Cardiac Function and Quality of Life in Patients with Chronic Heart Failure: A Randomized Controlled Trial.
    Li XX, Wu Y, Fan ZJ, Cui J, Li D, Lin Q, Zhuang R, Yan RK, Lin Q, Li Y.
    Chin J Integr Med; 2022 Jan 01; 28(1):12-19. PubMed ID: 34387827
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 8.